Trial intelligence / Profile preview

Acyclovir for Genital Ulcers and HIV Shedding in South African Men

NCT00164424Phase 3Completed

Sponsor
Centers for Disease Control and Prevention
Start
Mar 2005
Primary completion
Mar 2009
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

A Phase 3 trial of aciclovir in genital ulcer disease (GUD), herpes simplex virus type 2 infection, sponsored by Centers for Disease Control and Prevention. Started Mar 2005; status: completed.

02

Drugs

aciclovir
03

Conditions

genital ulcer disease (GUD)herpes simplex virus type 2 infection

Beyond the preview

Go deeper on NCT00164424.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00164424.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call